Brenntag AG (BNR) Receives Average Recommendation of “Buy” from Brokerages

Share on StockTwits

Shares of Brenntag AG (FRA:BNR) have earned an average recommendation of “Buy” from the fifteen brokerages that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is €52.79 ($61.38).

Several equities analysts recently commented on BNR shares. Commerzbank set a €45.00 ($52.33) price target on shares of Brenntag and gave the company a “neutral” rating in a report on Thursday, November 15th. Berenberg Bank set a €57.00 ($66.28) price target on shares of Brenntag and gave the company a “neutral” rating in a report on Wednesday, December 5th. JPMorgan Chase & Co. set a €50.00 ($58.14) price target on shares of Brenntag and gave the company a “buy” rating in a report on Thursday. Deutsche Bank set a €48.00 ($55.81) price target on shares of Brenntag and gave the company a “buy” rating in a report on Friday, November 23rd. Finally, UBS Group set a €55.00 ($63.95) price target on shares of Brenntag and gave the company a “buy” rating in a report on Monday, January 7th.

Shares of FRA BNR opened at €40.55 ($47.15) on Friday. Brenntag has a 12-month low of €43.06 ($50.07) and a 12-month high of €56.25 ($65.41).

About Brenntag

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

See Also: What is a stock split?

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Biocept  Shares Gap Down to $1.67
Biocept Shares Gap Down to $1.67
VirnetX  Shares Gap Up to $6.33
VirnetX Shares Gap Up to $6.33
Zacks: Brokerages Anticipate Repligen Co.  Will Post Quarterly Sales of $50.33 Million
Zacks: Brokerages Anticipate Repligen Co. Will Post Quarterly Sales of $50.33 Million
Stealth 24-Hour Volume Tops $138.00
Stealth 24-Hour Volume Tops $138.00
Molecular Future  1-Day Volume Tops $421,889.00
Molecular Future 1-Day Volume Tops $421,889.00
Deutsche Lufthansa AG  Receives Consensus Recommendation of “Hold” from Brokerages
Deutsche Lufthansa AG Receives Consensus Recommendation of “Hold” from Brokerages


Leave a Reply

© 2006-2019 Ticker Report